Exosomes participate in drug resistance, vascular remodeling, and antigen presentation. Exosomes not only impair the function of immune cells but also reshape the tumor microenvironment, thereby ...
MI Cancer Seek™ is the first FDA-approved test combining whole exome and transcriptome sequencing for solid tumor molecular profiling. The test identifies patients for targeted therapies in breast, ...
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the primary staging of non-small cell lung cancer (NSCLC). Application of an epigenomic-based classifier to identify cancer signal of origin on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback